Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis

被引:13
作者
Liang, Shuolin [1 ]
Qin, Qiuhong [2 ]
Tang, Yulan [1 ]
Liao, Weijing [3 ]
Yang, Yi [1 ]
He, Jinrong [1 ]
Li, Liangsheng [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Dept Histol, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Affiliated Wuming Hosp, Dept Neurol, Nanning 530199, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood-brain barrier (BBB); neuromyelitis optic spectrum disorders; newly diagnosis; optic neuritis; albumin quotient (qalb); T-CELLS; MULTIPLE-SCLEROSIS;
D O I
10.21037/apm.2019.12.12
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Blood-brain barrier (BBB) disruption and ensuing immune activation are central to the pathogenesis of central nervous system (CNS) inflammatory diseases. However, the influence of BBB permeability on the clinical signs and prognosis of newly diagnosed neuromyelitis optica spectrum disorder (NMOSD) has not been examined. We investigate the relationships between BBB permeability as showed by the albumin quotient (qalb) and clinical features of NMOSD. Methods: Demographic and clinical data of 46 patients, including peripheral blood (PB) measures (serum albumin concentration and total leukocyte, neutrophil, total lymphocyte, CD4+ T cell, and CD8+ T cell counts, complement C3 and C4 concentrations, AQP4-IgG titer),autoimmune antibody titers (ANA/SSA/SSB/ Ro-52), and cerebrospinal fluid (CSF) parameters (total leukocyte count, total protein and albumin concentrations, AQP4-IgG titer), were compared between qalb(BBB permeability) increased and normal groups. Complete measures were not obtained from 9 patients, but all other measures were included in the analysis. Results: According to the calculated qalb, 15 patients with albumin quotient (qalb) > (4 + age/15) x 10(-3) were assigned to the qalb increased (high BBB permeability) group (33%) and the remainder to the qalb normal group. Compared to the qalb normal group, the qalb increased group exhibited significantly lower serum albumin (P=0.001) and CD4+ T cell count (P=0.044), CD8+ T cell count (P=0.014), and total T lymphocyte count (P=0.016). The qalb increased group proved higher CSF albumin, total protein, leukocyte count, and IgG titer (all P=0.000). Optic neuritis and optic nerve abnormalities on magnetic resonance images were also more frequent in the qalb increased group (P=0.037 and 0.038, respectively). Patients in the qalb increased group showed significantly poorer treatment response as indicated by the lower post-treatment change in Expanded Disability Status Scale (EDSS) score compared to the qalb normal group. Conclusions: BBB permeability is strongly associated with the clinical features and treatment response of newly diagnosed NMOSD. The qalb is a potentially valuable indicator of disease severity and an index to guide personalized treatment.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 50 条
  • [41] Impact of Metabolic Syndrome on Neuroinflammation and the Blood-Brain Barrier
    Van Dyken, Peter
    Lacoste, Baptiste
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [42] The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier
    Tang, Wei
    Zhu, Huifeng
    Feng, Yanmei
    Guo, Rui
    Wan, Dong
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3351 - 3363
  • [43] Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
    Fiorentino, Maria
    Sapone, Anna
    Senger, Stefania
    Camhi, Stephanie S.
    Kadzielski, Sarah M.
    Buie, Timothy M.
    Kelly, Deanna L.
    Cascella, Nicola
    Fasano, Alessio
    MOLECULAR AUTISM, 2016, 7
  • [44] Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks
    Januel, Edouard
    Brochard, Vincent
    Le Guennec, Loic
    Maillart, Elisabeth
    Louapre, Celine
    Lubetzki, Catherine
    Weiss, Nicolas
    Demeret, Sophie
    Papeix, Caroline
    ANNALS OF INTENSIVE CARE, 2024, 14 (01)
  • [45] Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder
    Fan, Rong
    Zhang, Yuefeng
    Xu, Yunqi
    Tong, Jiayi
    Chen, Zhigang
    Gu, Meifeng
    Fan, Wenkui
    Chen, Yong
    Peng, Fuhua
    Jiang, Ying
    BRAIN AND BEHAVIOR, 2021, 11 (01):
  • [46] Cognitive function and brain magnetic resonance imaging profiles in neuromyelitis optica spectrum disorder and multiple sclerosis
    Ashtari, Fereshteh
    Najarzadeh, Pouran
    Shaygannejad, Vahid
    Adibi, Iman
    Ramezani, Neda
    Davanian, Fariba
    Akbaripour, Sahar
    Barekatain, Majid
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2024, 29 (01):
  • [47] Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients
    Carnero Contentti, Edgar
    Marques, Vanessa Daccach
    Soto de Castillo, Ibis
    Tkachuk, Veronica
    Barreira, Amilton Antunes
    Armas, Elizabeth
    Chiganer, Edson
    Cruz, Camila de Aquino
    Luis Di Pace, Jose
    Pablo Hryb, Javier
    Lavigne Moreira, Carolina
    Lessa, Carmen
    Molina, Omaira
    Perassolo, Monica
    Soto, Arnoldo
    Caride, Alejandro
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 19 : 73 - 78
  • [48] Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment
    Balasa, Rodica
    Barcutean, Laura
    Mosora, Oana
    Manu, Doina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [49] Cellular mechanisms of IL-17-induced blood-brain barrier disruption
    Huppert, Jula
    Closhen, Dorothea
    Croxford, Andrew
    White, Robin
    Kulig, Paulina
    Pietrowski, Eweline
    Bechmann, Ingo
    Becher, Burkhard
    Luhmann, Heiko J.
    Waisman, Ari
    Kuhlmann, Christoph R. W.
    FASEB JOURNAL, 2010, 24 (04) : 1023 - 1034
  • [50] Neuromyelitis optica spectrum disorder with radiological manifestation of multiple sclerosis in the first brain MRI: a case report
    Moghadasi, Abdorreza Naser
    Baghbanian, Seyed Mohammad
    FUTURE NEUROLOGY, 2019, 14 (02)